nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—Hepatic encephalopathy—Furosemide—dilated cardiomyopathy	0.0404	0.11	CcSEcCtD
Amiloride—SLC22A4—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.0245	0.0493	CbGpPWpGaD
Amiloride—Diuresis—Furosemide—dilated cardiomyopathy	0.0189	0.0514	CcSEcCtD
Amiloride—PLAU—cardiac ventricle—dilated cardiomyopathy	0.0175	0.129	CbGeAlD
Amiloride—SLC9A1—myocardium—dilated cardiomyopathy	0.0173	0.128	CbGeAlD
Amiloride—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.0166	0.0334	CbGpPWpGaD
Amiloride—PLAU—myocardium—dilated cardiomyopathy	0.0164	0.121	CbGeAlD
Amiloride—ASIC2—Stimuli-sensing channels—RYR2—dilated cardiomyopathy	0.0152	0.0306	CbGpPWpGaD
Amiloride—PLAU—Beta3 integrin cell surface interactions—LAMA4—dilated cardiomyopathy	0.0148	0.0298	CbGpPWpGaD
Amiloride—SCNN1D—heart—dilated cardiomyopathy	0.0129	0.0951	CbGeAlD
Amiloride—ASIC1—heart—dilated cardiomyopathy	0.0126	0.0933	CbGeAlD
Amiloride—Atrioventricular block complete—Lisinopril—dilated cardiomyopathy	0.0126	0.0342	CcSEcCtD
Amiloride—SLC9A1—heart—dilated cardiomyopathy	0.0121	0.0894	CbGeAlD
Amiloride—SLC22A2—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.0116	0.0233	CbGpPWpGaD
Amiloride—SCNN1D—Stimuli-sensing channels—RYR2—dilated cardiomyopathy	0.0115	0.0232	CbGpPWpGaD
Amiloride—ASIC1—Stimuli-sensing channels—RYR2—dilated cardiomyopathy	0.0115	0.0232	CbGpPWpGaD
Amiloride—SCNN1G—Stimuli-sensing channels—RYR2—dilated cardiomyopathy	0.0115	0.0232	CbGpPWpGaD
Amiloride—SCNN1A—Stimuli-sensing channels—RYR2—dilated cardiomyopathy	0.0115	0.0232	CbGpPWpGaD
Amiloride—SCNN1B—Stimuli-sensing channels—RYR2—dilated cardiomyopathy	0.0115	0.0232	CbGpPWpGaD
Amiloride—PLAU—heart—dilated cardiomyopathy	0.0115	0.0847	CbGeAlD
Amiloride—SCNN1B—heart—dilated cardiomyopathy	0.0109	0.0803	CbGeAlD
Amiloride—SLC22A1—Organic cation transport—SLC22A5—dilated cardiomyopathy	0.0108	0.0217	CbGpPWpGaD
Amiloride—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.0106	0.0288	CcSEcCtD
Amiloride—PLAU—Beta1 integrin cell surface interactions—LAMA4—dilated cardiomyopathy	0.0105	0.0211	CbGpPWpGaD
Amiloride—SLC9A1—cardiac atrium—dilated cardiomyopathy	0.0103	0.0765	CbGeAlD
Amiloride—SLC9A1—RhoA signaling pathway—VCL—dilated cardiomyopathy	0.0102	0.0205	CbGpPWpGaD
Amiloride—ASIC2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00993	0.02	CbGpPWpGaD
Amiloride—PLAU—cardiac atrium—dilated cardiomyopathy	0.00981	0.0725	CbGeAlD
Amiloride—ASIC2—Ion channel transport—PLN—dilated cardiomyopathy	0.00966	0.0194	CbGpPWpGaD
Amiloride—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00963	0.0262	CcSEcCtD
Amiloride—PLAU—FGF signaling pathway—PSEN1—dilated cardiomyopathy	0.00829	0.0167	CbGpPWpGaD
Amiloride—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00786	0.0158	CbGpPWpGaD
Amiloride—ASIC1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00753	0.0151	CbGpPWpGaD
Amiloride—SCNN1A—Ion channel transport—RYR2—dilated cardiomyopathy	0.00753	0.0151	CbGpPWpGaD
Amiloride—SCNN1G—Ion channel transport—RYR2—dilated cardiomyopathy	0.00753	0.0151	CbGpPWpGaD
Amiloride—SCNN1B—Ion channel transport—RYR2—dilated cardiomyopathy	0.00753	0.0151	CbGpPWpGaD
Amiloride—SCNN1D—Ion channel transport—RYR2—dilated cardiomyopathy	0.00753	0.0151	CbGpPWpGaD
Amiloride—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.00733	0.0147	CbGpPWpGaD
Amiloride—ASIC1—Ion channel transport—PLN—dilated cardiomyopathy	0.00732	0.0147	CbGpPWpGaD
Amiloride—SCNN1G—Ion channel transport—PLN—dilated cardiomyopathy	0.00732	0.0147	CbGpPWpGaD
Amiloride—SCNN1B—Ion channel transport—PLN—dilated cardiomyopathy	0.00732	0.0147	CbGpPWpGaD
Amiloride—SCNN1D—Ion channel transport—PLN—dilated cardiomyopathy	0.00732	0.0147	CbGpPWpGaD
Amiloride—SCNN1A—Ion channel transport—PLN—dilated cardiomyopathy	0.00732	0.0147	CbGpPWpGaD
Amiloride—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00703	0.0191	CcSEcCtD
Amiloride—Heartburn—Lisinopril—dilated cardiomyopathy	0.00638	0.0174	CcSEcCtD
Amiloride—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00631	0.0172	CcSEcCtD
Amiloride—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00622	0.0169	CcSEcCtD
Amiloride—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00596	0.0162	CcSEcCtD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—GJA1—dilated cardiomyopathy	0.0057	0.0115	CbGpPWpGaD
Amiloride—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.0055	0.015	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	0.00535	0.0108	CbGpPWpGaD
Amiloride—Urine output increased—Furosemide—dilated cardiomyopathy	0.00529	0.0144	CcSEcCtD
Amiloride—SLC9A1—RhoA signaling pathway—ITGB1—dilated cardiomyopathy	0.00512	0.0103	CbGpPWpGaD
Amiloride—PLAU—Osteopontin-mediated events—RAC1—dilated cardiomyopathy	0.005	0.0101	CbGpPWpGaD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—ITGB1—dilated cardiomyopathy	0.00488	0.00981	CbGpPWpGaD
Amiloride—Polyuria—Furosemide—dilated cardiomyopathy	0.00484	0.0132	CcSEcCtD
Amiloride—Alopecia—Spironolactone—dilated cardiomyopathy	0.00478	0.013	CcSEcCtD
Amiloride—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00452	0.0123	CcSEcCtD
Amiloride—Thirst—Furosemide—dilated cardiomyopathy	0.00447	0.0122	CcSEcCtD
Amiloride—Neck pain—Lisinopril—dilated cardiomyopathy	0.00445	0.0121	CcSEcCtD
Amiloride—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00432	0.0117	CcSEcCtD
Amiloride—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00427	0.0116	CcSEcCtD
Amiloride—SLC22A4—heart—dilated cardiomyopathy	0.00402	0.0297	CbGeAlD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—RAC1—dilated cardiomyopathy	0.00392	0.00789	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.00391	0.00787	CbGpPWpGaD
Amiloride—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00388	0.0106	CcSEcCtD
Amiloride—Confusional state—Spironolactone—dilated cardiomyopathy	0.00387	0.0105	CcSEcCtD
Amiloride—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00383	0.0104	CcSEcCtD
Amiloride—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00375	0.0102	CcSEcCtD
Amiloride—Abdominal distension—Furosemide—dilated cardiomyopathy	0.0037	0.0101	CcSEcCtD
Amiloride—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00365	0.00993	CcSEcCtD
Amiloride—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.0035	0.00953	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00346	0.00695	CbGpPWpGaD
Amiloride—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00344	0.00936	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	0.00342	0.00688	CbGpPWpGaD
Amiloride—Somnolence—Spironolactone—dilated cardiomyopathy	0.00341	0.00929	CcSEcCtD
Amiloride—PLAU—Beta1 integrin cell surface interactions—ITGB1—dilated cardiomyopathy	0.0034	0.00684	CbGpPWpGaD
Amiloride—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00339	0.00923	CcSEcCtD
Amiloride—ASIC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00336	0.00676	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00336	0.00676	CbGpPWpGaD
Amiloride—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00333	0.0067	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00331	0.00902	CcSEcCtD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00331	0.00665	CbGpPWpGaD
Amiloride—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.0032	0.00871	CcSEcCtD
Amiloride—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00319	0.00868	CcSEcCtD
Amiloride—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00316	0.00861	CcSEcCtD
Amiloride—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00316	0.00861	CcSEcCtD
Amiloride—SLC9A1—Endothelins—RAC1—dilated cardiomyopathy	0.00314	0.00632	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00313	0.00629	CbGpPWpGaD
Amiloride—ASIC2—Stimuli-sensing channels—RAF1—dilated cardiomyopathy	0.003	0.00604	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—IL10—dilated cardiomyopathy	0.00297	0.00596	CbGpPWpGaD
Amiloride—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00291	0.00793	CcSEcCtD
Amiloride—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00287	0.00781	CcSEcCtD
Amiloride—Visual impairment—Furosemide—dilated cardiomyopathy	0.00283	0.00771	CcSEcCtD
Amiloride—Tinnitus—Furosemide—dilated cardiomyopathy	0.00274	0.00746	CcSEcCtD
Amiloride—Pruritus—Spironolactone—dilated cardiomyopathy	0.00272	0.00739	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway—RAC1—dilated cardiomyopathy	0.0027	0.00543	CbGpPWpGaD
Amiloride—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00268	0.00731	CcSEcCtD
Amiloride—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00263	0.00715	CcSEcCtD
Amiloride—ASIC1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00262	0.00527	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00262	0.00527	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00262	0.00527	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00262	0.00527	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00262	0.00527	CbGpPWpGaD
Amiloride—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00258	0.00701	CcSEcCtD
Amiloride—Dysuria—Lisinopril—dilated cardiomyopathy	0.00258	0.00701	CcSEcCtD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00255	0.00513	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00255	0.00513	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00255	0.00513	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00255	0.00513	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00255	0.00513	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00255	0.00513	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00255	0.00513	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00255	0.00513	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00255	0.00513	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00255	0.00513	CbGpPWpGaD
Amiloride—Dizziness—Spironolactone—dilated cardiomyopathy	0.00254	0.00691	CcSEcCtD
Amiloride—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00254	0.00691	CcSEcCtD
Amiloride—Flatulence—Furosemide—dilated cardiomyopathy	0.00252	0.00686	CcSEcCtD
Amiloride—PLAU—AP-1 transcription factor network—AGT—dilated cardiomyopathy	0.00249	0.00501	CbGpPWpGaD
Amiloride—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00246	0.0067	CcSEcCtD
Amiloride—Depression—Lisinopril—dilated cardiomyopathy	0.00245	0.00667	CcSEcCtD
Amiloride—Vomiting—Spironolactone—dilated cardiomyopathy	0.00244	0.00664	CcSEcCtD
Amiloride—Rash—Spironolactone—dilated cardiomyopathy	0.00242	0.00659	CcSEcCtD
Amiloride—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00242	0.00658	CcSEcCtD
Amiloride—Headache—Spironolactone—dilated cardiomyopathy	0.00241	0.00655	CcSEcCtD
Amiloride—Jaundice—Lisinopril—dilated cardiomyopathy	0.0024	0.00652	CcSEcCtD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00237	0.00477	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00237	0.00477	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00237	0.00477	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00237	0.00477	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00237	0.00477	CbGpPWpGaD
Amiloride—Vertigo—Furosemide—dilated cardiomyopathy	0.0023	0.00626	CcSEcCtD
Amiloride—Nausea—Spironolactone—dilated cardiomyopathy	0.00228	0.00621	CcSEcCtD
Amiloride—SCNN1G—Stimuli-sensing channels—RAF1—dilated cardiomyopathy	0.00228	0.00458	CbGpPWpGaD
Amiloride—SCNN1D—Stimuli-sensing channels—RAF1—dilated cardiomyopathy	0.00228	0.00458	CbGpPWpGaD
Amiloride—SCNN1B—Stimuli-sensing channels—RAF1—dilated cardiomyopathy	0.00228	0.00458	CbGpPWpGaD
Amiloride—SCNN1A—Stimuli-sensing channels—RAF1—dilated cardiomyopathy	0.00228	0.00458	CbGpPWpGaD
Amiloride—ASIC1—Stimuli-sensing channels—RAF1—dilated cardiomyopathy	0.00228	0.00458	CbGpPWpGaD
Amiloride—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00225	0.00611	CcSEcCtD
Amiloride—PLAU—amb2 Integrin signaling—TNF—dilated cardiomyopathy	0.00211	0.00425	CbGpPWpGaD
Amiloride—Confusional state—Furosemide—dilated cardiomyopathy	0.00211	0.00573	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—RAC1—dilated cardiomyopathy	0.00209	0.0042	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—SOD2—dilated cardiomyopathy	0.00209	0.0042	CbGpPWpGaD
Amiloride—SLC9A1—Endothelins—RAF1—dilated cardiomyopathy	0.00208	0.00419	CbGpPWpGaD
Amiloride—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00206	0.0056	CcSEcCtD
Amiloride—Shock—Furosemide—dilated cardiomyopathy	0.00206	0.00559	CcSEcCtD
Amiloride—Anorexia—Furosemide—dilated cardiomyopathy	0.00199	0.00542	CcSEcCtD
Amiloride—ASIC2—Ion channel transport—RAF1—dilated cardiomyopathy	0.00196	0.00394	CbGpPWpGaD
Amiloride—Alopecia—Lisinopril—dilated cardiomyopathy	0.00195	0.0053	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—FASLG—dilated cardiomyopathy	0.00193	0.00389	CbGpPWpGaD
Amiloride—Flatulence—Lisinopril—dilated cardiomyopathy	0.00189	0.00515	CcSEcCtD
Amiloride—Tension—Lisinopril—dilated cardiomyopathy	0.00188	0.00513	CcSEcCtD
Amiloride—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00188	0.0051	CcSEcCtD
Amiloride—Nervousness—Lisinopril—dilated cardiomyopathy	0.00187	0.00508	CcSEcCtD
Amiloride—Back pain—Lisinopril—dilated cardiomyopathy	0.00186	0.00505	CcSEcCtD
Amiloride—Somnolence—Furosemide—dilated cardiomyopathy	0.00186	0.00505	CcSEcCtD
Amiloride—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00185	0.00502	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—RAC1—dilated cardiomyopathy	0.00183	0.00368	CbGpPWpGaD
Amiloride—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00182	0.00494	CcSEcCtD
Amiloride—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.0018	0.00491	CcSEcCtD
Amiloride—Fatigue—Furosemide—dilated cardiomyopathy	0.0018	0.0049	CcSEcCtD
Amiloride—PLAU—Hemostasis—TTN—dilated cardiomyopathy	0.0018	0.00362	CbGpPWpGaD
Amiloride—Tremor—Lisinopril—dilated cardiomyopathy	0.0018	0.0049	CcSEcCtD
Amiloride—Pain—Furosemide—dilated cardiomyopathy	0.00179	0.00486	CcSEcCtD
Amiloride—Constipation—Furosemide—dilated cardiomyopathy	0.00179	0.00486	CcSEcCtD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—dilated cardiomyopathy	0.00178	0.00359	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00173	0.00347	CbGpPWpGaD
Amiloride—Vertigo—Lisinopril—dilated cardiomyopathy	0.00173	0.0047	CcSEcCtD
Amiloride—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00172	0.00468	CcSEcCtD
Amiloride—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00171	0.00465	CcSEcCtD
Amiloride—Palpitations—Lisinopril—dilated cardiomyopathy	0.0017	0.00462	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00168	0.00338	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00168	0.00338	CbGpPWpGaD
Amiloride—Cough—Lisinopril—dilated cardiomyopathy	0.00168	0.00456	CcSEcCtD
Amiloride—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00165	0.00449	CcSEcCtD
Amiloride—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00163	0.00445	CcSEcCtD
Amiloride—Chest pain—Lisinopril—dilated cardiomyopathy	0.00163	0.00445	CcSEcCtD
Amiloride—Confusional state—Lisinopril—dilated cardiomyopathy	0.00158	0.0043	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00158	0.00318	CbGpPWpGaD
Amiloride—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00158	0.00317	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00156	0.00314	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ACTN2—dilated cardiomyopathy	0.00156	0.00314	CbGpPWpGaD
Amiloride—Shock—Lisinopril—dilated cardiomyopathy	0.00154	0.0042	CcSEcCtD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00151	0.00304	CbGpPWpGaD
Amiloride—Asthenia—Furosemide—dilated cardiomyopathy	0.0015	0.00408	CcSEcCtD
Amiloride—Anorexia—Lisinopril—dilated cardiomyopathy	0.00149	0.00407	CcSEcCtD
Amiloride—SCNN1B—Ion channel transport—RAF1—dilated cardiomyopathy	0.00149	0.00299	CbGpPWpGaD
Amiloride—ASIC1—Ion channel transport—RAF1—dilated cardiomyopathy	0.00149	0.00299	CbGpPWpGaD
Amiloride—SCNN1G—Ion channel transport—RAF1—dilated cardiomyopathy	0.00149	0.00299	CbGpPWpGaD
Amiloride—SCNN1D—Ion channel transport—RAF1—dilated cardiomyopathy	0.00149	0.00299	CbGpPWpGaD
Amiloride—SCNN1A—Ion channel transport—RAF1—dilated cardiomyopathy	0.00149	0.00299	CbGpPWpGaD
Amiloride—Pruritus—Furosemide—dilated cardiomyopathy	0.00148	0.00402	CcSEcCtD
Amiloride—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00147	0.00295	CbGpPWpGaD
Amiloride—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00143	0.00389	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00143	0.00389	CcSEcCtD
Amiloride—Insomnia—Lisinopril—dilated cardiomyopathy	0.00142	0.00386	CcSEcCtD
Amiloride—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00141	0.00383	CcSEcCtD
Amiloride—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.0014	0.0038	CcSEcCtD
Amiloride—Somnolence—Lisinopril—dilated cardiomyopathy	0.00139	0.00379	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—RAF1—dilated cardiomyopathy	0.00139	0.00279	CbGpPWpGaD
Amiloride—Dizziness—Furosemide—dilated cardiomyopathy	0.00138	0.00376	CcSEcCtD
Amiloride—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00138	0.00375	CcSEcCtD
Amiloride—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00136	0.00371	CcSEcCtD
Amiloride—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00135	0.00368	CcSEcCtD
Amiloride—Fatigue—Lisinopril—dilated cardiomyopathy	0.00135	0.00368	CcSEcCtD
Amiloride—Constipation—Lisinopril—dilated cardiomyopathy	0.00134	0.00365	CcSEcCtD
Amiloride—Pain—Lisinopril—dilated cardiomyopathy	0.00134	0.00365	CcSEcCtD
Amiloride—Vomiting—Furosemide—dilated cardiomyopathy	0.00133	0.00361	CcSEcCtD
Amiloride—PLAU—Hemostasis—VCL—dilated cardiomyopathy	0.00133	0.00267	CbGpPWpGaD
Amiloride—Rash—Furosemide—dilated cardiomyopathy	0.00132	0.00358	CcSEcCtD
Amiloride—Dermatitis—Furosemide—dilated cardiomyopathy	0.00132	0.00358	CcSEcCtD
Amiloride—Headache—Furosemide—dilated cardiomyopathy	0.00131	0.00356	CcSEcCtD
Amiloride—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00129	0.00351	CcSEcCtD
Amiloride—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00128	0.00349	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—RAF1—dilated cardiomyopathy	0.00125	0.00251	CbGpPWpGaD
Amiloride—Nausea—Furosemide—dilated cardiomyopathy	0.00124	0.00338	CcSEcCtD
Amiloride—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00124	0.00337	CcSEcCtD
Amiloride—SLC9A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.00114	0.00228	CbGpPWpGaD
Amiloride—Asthenia—Lisinopril—dilated cardiomyopathy	0.00112	0.00306	CcSEcCtD
Amiloride—Pruritus—Lisinopril—dilated cardiomyopathy	0.00111	0.00302	CcSEcCtD
Amiloride—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00107	0.00292	CcSEcCtD
Amiloride—SLC9A1—Metabolism—TAZ—dilated cardiomyopathy	0.00107	0.00215	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00105	0.00211	CbGpPWpGaD
Amiloride—Dizziness—Lisinopril—dilated cardiomyopathy	0.00104	0.00282	CcSEcCtD
Amiloride—Vomiting—Lisinopril—dilated cardiomyopathy	0.000997	0.00271	CcSEcCtD
Amiloride—Rash—Lisinopril—dilated cardiomyopathy	0.000988	0.00269	CcSEcCtD
Amiloride—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000987	0.00269	CcSEcCtD
Amiloride—Headache—Lisinopril—dilated cardiomyopathy	0.000982	0.00267	CcSEcCtD
Amiloride—SLC9A1—Metabolism—SDHA—dilated cardiomyopathy	0.000966	0.00194	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—EGFR—dilated cardiomyopathy	0.00095	0.00191	CbGpPWpGaD
Amiloride—Nausea—Lisinopril—dilated cardiomyopathy	0.000931	0.00253	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000791	0.00159	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000787	0.00158	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000769	0.00155	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000769	0.00155	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000734	0.00148	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000718	0.00144	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000716	0.00144	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000715	0.00144	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000682	0.00137	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000667	0.00134	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ITGB1—dilated cardiomyopathy	0.000666	0.00134	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000629	0.00126	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000603	0.00121	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NPPA—dilated cardiomyopathy	0.00059	0.00119	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000586	0.00118	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PSEN2—dilated cardiomyopathy	0.000572	0.00115	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—CD36—dilated cardiomyopathy	0.000568	0.00114	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000562	0.00113	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—RAC1—dilated cardiomyopathy	0.000536	0.00108	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000517	0.00104	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000517	0.00104	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000517	0.00104	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000517	0.00104	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000517	0.00104	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000374	0.000752	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000364	0.000732	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000364	0.000732	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—RAF1—dilated cardiomyopathy	0.000355	0.000714	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000349	0.000701	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000341	0.000685	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000339	0.000682	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000339	0.000682	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000338	0.00068	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000315	0.000634	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RAC1—dilated cardiomyopathy	0.000287	0.000578	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GPX1—dilated cardiomyopathy	0.000262	0.000528	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CD36—dilated cardiomyopathy	0.000255	0.000514	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000246	0.000494	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	0.000231	0.000465	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AGT—dilated cardiomyopathy	0.00023	0.000463	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000229	0.000461	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TAZ—dilated cardiomyopathy	0.000215	0.000433	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	0.000209	0.00042	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SDHA—dilated cardiomyopathy	0.000195	0.000392	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RAF1—dilated cardiomyopathy	0.000191	0.000383	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000179	0.00036	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000167	0.000336	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000156	0.000314	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	0.000137	0.000276	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EGFR—dilated cardiomyopathy	0.000131	0.000263	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	0.000128	0.000257	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.38e-05	0.000148	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.88e-05	0.000138	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	5.68e-05	0.000114	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	5.53e-05	0.000111	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	5.29e-05	0.000106	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	5.15e-05	0.000104	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	4.98e-05	0.0001	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	4.64e-05	9.33e-05	CbGpPWpGaD
